Design and in vivo Evaluation of Gastro-retentive Floating Capsules of Amlodipine Besylate in Healthy Human Volunteers
DOI:
https://doi.org/10.37285/ijpsn.2017.10.6.3Abstract
The aim of this study was to explore the application of Gelucire 43/01 for the design of sustained release gastro retentive drug delivery system of Amlodipine besylate. Gelucire 43/01 has been used in floating sustained release formulations to prolong gastric residence time and increase its bioavailability. Gelucire 43/01 in combination with HPMC and Polyox was used as a release retarding polymer. HPMC of various viscosity grades HPMC K4M, HPMC K15M and HPMC K100M in combination of Gelucire were tested to obtain optimal total floating time as well as controlled drug release for prolonged period. Melt granulation technique has been used to prepare gastro retentive Amlodipine besylate formulations. All the formulations were evaluated in vitro for their floating ability and drug release. The floating times of all tablet formulations were greater than 12h. HPMC K4M in combination with Gelucire as polymeric matrix enhanced the drug release due to addition of hydrophilic polymer facilitated the swelling and erosion of the tablets. Incorporation of low viscosity polymer HPMC K100 M resulted in optimal floating as well as drug release for longer time. In vivo studies of optimized formulation show floating ability for 6 h in stomach. The results indicate that Gelucire 43/01 in combination with dissolution enhancers HPMC increase the permeability of the wax matrix, which provides improved dissolution thereby bioavailability of Amlodipine besylate and can be considered as a carrier for the development of sustained release floating drug delivery systems.
Downloads
Metrics
Keywords:
Amlodipine, Floating delivery, Radiographic studies, Gelucire 43/01, Bioavailability, HPMC
Downloads
Published
How to Cite
Issue
Section
References
Baumgartner S, Kristl J, Vrecer F, Vodopivec P and Zorko B (2000). Optimization of floating matrix tablets and evaluation of their gastric residence time. Int J Pharm 195: 125-135.
Bogentoft C (1982). Oral controlled-release dosage forms in perspective. Pharm Int 3: 366-369.
Chen J, Blevins WE and Park H (2000). Park, Gastric retention properties of super porous hydrogel composites. J Contr Rel 65: 73-82.
Ching HS, Park H, Kelly P and Robinson JR (1985). Bioadhesive polymers as platform for oral controlled drug delivery. II. Synthesis and evaluation of some swelling water-insoluble bioadhesive polymers. J Pharm Sci 74: 399-405.
Deshpande AA, Shah, NH, Rhodes, CT, Malick, W (1997). Development of a novel controlled-release system for gastric retention. Pharm. Res 7, 14, 815-819.
Efentakis M, Koutlis A and Vlachou M (2000). Development and evaluation of oral multiple-unit and single-unit hydrophilic controlled-release systems. AAPS Pharm SciTech 1(4): E34.
Iannuccelli V, Coppi G, Bernabei MT and Cameroni R (1998). Air compartment multiple-unit system for prolonged gastric residence. Int J Pharm 174: 47–54.
Li S, Lin, S, Daggy BP, Mirchandani HL and Chien YW (2003). Effect of HPMC and Carbopol on the release and floating properties of Gastric Floating Drug Delivery System using factorial design. Int J Pharm 253: 13–22.
Kaniwa N, Aoyagi N, Ogata H and Ejima A (1988). Gastric emptying of enteric coated drug preparations. II. Effect of size and density of enteric coated drug preparations and food on the gastric emptying rates in humans. J Pharmacobiodyn 11: 571-575.
Nayak A.K. and Malakar J (2011). Formulation and in vitro evaluation of hydrodynamically balanced system for theophylline delivery. J Basic Clin Pharm 2: 133-139.
Ohmori M, Arakawa M, Takasali H, Hifumi S and Fujimura A (2003). Stereo selective pharmacokinetics of amlodipine besylate in elderly hypertensive. Am J Ther 10: 29-31.
Preda M and Leucuta SE (2003). Oxpernolol-loaded bioadhesive microspheres: preparation and in vitro/in vivo characterization. J Microencapsul 20(6): 777-789.
Rouge N, Allemann E, Gex-Fabry M, Balant L, Cole ET, Buri E and Doelker E (1998). Comparative pharmacokinetic study of a floating multiple-unit capsule, a high density multiple-unit capsule and an immediate-release tablet containing 25 mg atenolol. Pharm Acta Helbet 73: 81-87.
Sheth PR and Tossounian JL (1978). Sustained release pharmaceutical capsules, US Patent 4.1978,126,672.
Shimpi S, Chauhan B and Mahadik KR Paradkar A (2004). Preparation and evaluation of Diltiazem Hydrochloride Gelucire 43/01 floating granules prepared by Melt Granulation, AAPS Pharm Sci Tech 5,3: E1.
Singh B, Sharma V and Cahuhan D (2010). Gastroretentive floating sterculia-alginate beads for use in antiulcer drug delivery. Chem Eng Res Des 88: 997-1012.
Streubel A, Siepmann J and Bodmeier R (2002). Floating microparticles based on low density foam powder. Int J Pharm 241: 279-292.
Streubel A, Siepmann J and Bodmeier R (2003). Gastro retentive drug delivery systems. Expert Opin Drug Delivery 6, 3(2): 217-233.
Torre PM, Torrado G and Torrado S (2005). Poly (acrylic acid) chitosan interpolymer complexes for stomach controlled antibiotic delivery. J. Biomed. Mater. Res. B: Appl. Biomater 72: 191-197.
Zuleger S and Lippold BC (2001). Polymer particle erosion controlling drug release. Factors influencing drug release and characterization of the release mechanism. Int J Pharm 217: 139-152.
